- Home
- TSHA vs ASPI Comparison
TSHA vs ASPI Comparison
Compare TSHA & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- ASPI
- Stock Information
- Founded
- TSHA 2019
- ASPI 2021
- Country
- TSHA United States
- ASPI United States
- Employees
- TSHA N/A
- ASPI N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- ASPI Major Chemicals
- Sector
- TSHA Health Care
- ASPI Industrials
- Exchange
- TSHA Nasdaq
- ASPI Nasdaq
- Market Cap
- TSHA 397.8M
- ASPI 470.6M
- IPO Year
- TSHA 2020
- ASPI 2022
- Fundamental
- Price
- TSHA $2.13
- ASPI $6.43
- Analyst Decision
- TSHA Strong Buy
- ASPI Strong Buy
- Analyst Count
- TSHA 8
- ASPI 2
- Target Price
- TSHA $6.63
- ASPI $4.50
- AVG Volume (30 Days)
- TSHA 3.0M
- ASPI 1.9M
- Earning Date
- TSHA 05-16-2025
- ASPI 05-19-2025
- Dividend Yield
- TSHA N/A
- ASPI N/A
- EPS Growth
- TSHA N/A
- ASPI N/A
- EPS
- TSHA N/A
- ASPI N/A
- Revenue
- TSHA $8,333,000.00
- ASPI $4,144,225.00
- Revenue This Year
- TSHA N/A
- ASPI $690.06
- Revenue Next Year
- TSHA N/A
- ASPI $93.09
- P/E Ratio
- TSHA N/A
- ASPI N/A
- Revenue Growth
- TSHA N/A
- ASPI 857.04
- 52 Week Low
- TSHA $1.05
- ASPI $1.86
- 52 Week High
- TSHA $4.32
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- TSHA 58.69
- ASPI 64.32
- Support Level
- TSHA $1.85
- ASPI $5.16
- Resistance Level
- TSHA $2.28
- ASPI $5.95
- Average True Range (ATR)
- TSHA 0.26
- ASPI 0.43
- MACD
- TSHA 0.03
- ASPI 0.04
- Stochastic Oscillator
- TSHA 52.96
- ASPI 98.94
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.